William Blair analyst Mylers Minter reiterated an Outperform rating on Dianthus Therapeutics (NASDAQ: DNTH)The analyst commented, "Dianthus’s update of written ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE